Scripta co-founder and Chief Medical Officer Paul Bradley, MD, has been one of the key players in the path to market for the critical, life-saving COVID-19 vaccines. In addition to treating his own patients on the frontline of this pandemic, he has led the Moderna, Pfizer and Novavax COVID-19 vaccine clinical trials as Principal Investigator at Meridian Clinical Research's Internal Medicine site in Savannah, GA.
 

Over the last year, Dr. Bradley has dosed more than 1,000 patients across these clinical trials, dosing the first patient in Moderna's Phase 3 trial with much fanfare. He has worked closely with government agencies and the Operation Warp Speed team, and his own COVID-19 vaccination was even documented by major news networks.
 

Dr. Bradley sat down recently with our CEO Eric Levin to talk about the history-making journey to COVID-19 vaccine emergency authorization, talk vaccine safety, efficacy & rollout, and offer employers strategies for returning to the workplace safely.

​

We hope this complimentary educational video series helps as you formulate your vaccine strategy and plan for return to work. We'll continue to update our video library with the most current information & insights as things unfold.